118 related articles for article (PubMed ID: 2120833)
41. Prevalence of hepatitis C in transfusion dependent thalassaemics & haemophilics.
Bhattacharya DK; Bhattacharjee S; De M; Lahiri P
Indian J Med Res; 1991 Dec; 94():430-2. PubMed ID: 1774095
[TBL] [Abstract][Full Text] [Related]
42. [Serum antibodies against hepatitis C: study of 4,100 blood donors from the northeast of France].
Aymard JP; Janot C; Adjizian JC; Tamisier C; Humbert JC; Billuart M; Streiff F
Rev Fr Transfus Hemobiol; 1990 Jul; 33(4):295-302. PubMed ID: 2171543
[TBL] [Abstract][Full Text] [Related]
43. Incidence of anti-hepatitis C virus antibodies in non-A, non-B post-transfusion hepatitis in an area of northern Italy.
Elia GF; Magnani G; Belli L; Formentini A; Iacono S; Marchelli S; Pincolini S; Lecchini R; Bernuzzi G; Fiaccadori F
Infection; 1991; 19(5):336-9. PubMed ID: 1666064
[TBL] [Abstract][Full Text] [Related]
44. [Post-transfusional hepatitis in the city of Campinas, SP, Brazil. II. Presence of anti-HBc and anti-HCV antibodies in blood donor candidates and occurrence of post-transfusional hepatitis C in recipients of blood or derivates].
Gonçales Júnior FL; Pedro Rde J; da Silva LJ; Boccato RS; Gonçales NS
Rev Inst Med Trop Sao Paulo; 1993; 35(1):63-71. PubMed ID: 7506447
[TBL] [Abstract][Full Text] [Related]
45. [Incidence of hepatitis C virus antibodies in blood donors, high risk patient groups, liver diseases and health professionals. Multicenter study of the ABBOT ELISA method, comparison with the ORTHO test].
Pár A
Orv Hetil; 1991 May; 132(18):955-9. PubMed ID: 1902928
[TBL] [Abstract][Full Text] [Related]
46. [The prevalence of anti-HCV positivity among blood donors in Asturias. A clinical-epidemiologic study].
Suárez A; Rodríguez M; Riestra S; Navascués CA; San Román FS; Otero L; Martínez A; Rodrigo L
Med Clin (Barc); 1994 Nov; 103(16):606-10. PubMed ID: 7996916
[TBL] [Abstract][Full Text] [Related]
47. Antibodies to hepatitis C virus in blood donors.
Ferroni P; Tagger A; Ribero ML; Grossi A; Pregliasco F; Pasquali ML; Salvaneschi S
Eur J Epidemiol; 1990 Sep; 6(3):326-8. PubMed ID: 2174795
[TBL] [Abstract][Full Text] [Related]
48. Anti-hepatitis C antibodies and non-A, non-B post-transfusion hepatitis in The Netherlands.
van der Poel CL; Reesink HW; Lelie PN; Leentvaar-Kuypers A; Choo QL; Kuo G; Houghton M
Lancet; 1989 Aug; 2(8658):297-8. PubMed ID: 2569103
[TBL] [Abstract][Full Text] [Related]
49. Hepatitis C virus antibody in Poland.
Laskus T; Radkowski M; Lupa E; Cianciara J; Slusarczyk J; Halama G; Horban A
Scand J Infect Dis; 1991; 23(3):385-6. PubMed ID: 1715607
[TBL] [Abstract][Full Text] [Related]
50. [Incidence of anti-HCV and ALT in blood donors].
Martín Y; Marzo L; Cinto F; Delgado P; Buñuel C
Sangre (Barc); 1990 Jun; 35(3):197-200. PubMed ID: 2118686
[TBL] [Abstract][Full Text] [Related]
51. Development of antibody to hepatitis C virus (HCV) in acute and chronic non-A, non-B post-transfusion hepatitis.
Pastore G; Monno L; Milella M; Santantonio T; Rumi MG; Colombo M; Giannelli A; Fico C; De Stasio G; Lattanzio A
Eur J Epidemiol; 1992 Jul; 8(4):580-4. PubMed ID: 1327865
[TBL] [Abstract][Full Text] [Related]
52. Non-A, non-B hepatitis and antibody to hepatitis C virus.
Mosley JW; Aach RD; Hollinger FB; Stevens CE; Barbosa LH; Nemo GJ; Holland PV; Bancroft WH; Zimmerman HJ; Kuo G
JAMA; 1990 Jan; 263(1):77-8. PubMed ID: 2104549
[TBL] [Abstract][Full Text] [Related]
53. Prevalence of hepatitis C in South Africa: detection of anti-HCV in recent and stored serum.
Ellis LA; Brown D; Conradie JD; Paterson A; Sher R; Millo J; Theodossiadou E; Dusheiko GM
J Med Virol; 1990 Dec; 32(4):249-51. PubMed ID: 2127942
[TBL] [Abstract][Full Text] [Related]
54. [Anti-HCV antibodies among blood donors in Cantabria. Incidence and relation to transaminase levels].
Pastor JM; Hermosa V; Ruiz Tagle MA; Zubizarreta A
Sangre (Barc); 1990 Jun; 35(3):205-7. PubMed ID: 2118687
[TBL] [Abstract][Full Text] [Related]
55. [Changes in the prevalence of anti-HCV in blood donors in Asturias].
Suárez A; San Román F; Rodríguez M; Rodrigo L
Med Clin (Barc); 1992 Oct; 99(13):515. PubMed ID: 1434977
[No Abstract] [Full Text] [Related]
56. Post-transfusion hepatitis: impact of non-A, non-B hepatitis surrogate tests. Canadian Post-Transfusion Hepatitis Prevention Study Group.
Blajchman MA; Bull SB; Feinman SV
Lancet; 1995 Jan; 345(8941):21-5. PubMed ID: 7528310
[TBL] [Abstract][Full Text] [Related]
57. Sexual transmission of hepatitis C virus: cohort study (1981-9) among European homosexual men.
Melbye M; Biggar RJ; Wantzin P; Krogsgaard K; Ebbesen P; Becker NG
BMJ; 1990 Jul; 301(6745):210-2. PubMed ID: 2118402
[TBL] [Abstract][Full Text] [Related]
58. [Current status of anti-HCV screening and posttransfusion hepatitis].
Kiyokawa H
Rinsho Byori; 1992 Sep; 40(9):925-8. PubMed ID: 1279246
[TBL] [Abstract][Full Text] [Related]
59. Prevalence of hepatitis C virus antibodies in Italian blood donors. The Italian Cooperative Group.
Sirchia G; Almini D; Bellobuono A; Giovanetti AM; Marconi M; Mercuriali F; Mozzi F; Parravicini A; Pizzi M; Zanuso F
Vox Sang; 1990; 59(1):26-9. PubMed ID: 2118697
[TBL] [Abstract][Full Text] [Related]
60. [Epidemiologic study of anti-HCV antibodies in Tunisian blood donors].
Slama H; Mojaat N; Dahri R; Boukef K
Rev Fr Transfus Hemobiol; 1991 Dec; 34(6):459-64. PubMed ID: 1663358
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
